Episealer® Knee technology and clinical results to be presented at scientific congress in the US
Episurf Medical (Nasdaq: EPIS B) today announces that the Episealer® Knee technology and clinical results will be presented at the 6th ICRS Summit (International Cartilage Regeneration and Joint Preservation Society) in Miami, US, on November 17-19. The presentation is a part of the scientific program within the session Evolving New Technologies Unloading Procedures & Focal Resurfacing. The presentation is held by Associate Professor Tim Spalding, Cleveland Clinic, London, UK.
“The ICRS Summit is a meeting that brings together many of the leading experts in the field of joint preservation, and we highly appreciate their interest shown in our technology. The fact that this presentation will take place when the ICRS Summit is held in the US is very suitable for us as we intend to launch our first products on the US market in the coming year”, says Pål Ryfors, CEO, Episurf Medical AB.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
Tags: